Aino Latva-Rasku
MD, PhD, postdoctoral fellow
Turku PET Centre aehyyp@utu.fi ORCID identifier: https://orcid.org/0000-0001-8786-9160 |
Areas of expertise
Insulin resistance; insulin actions; positron emission tomography (PET)
Insulin resistance; insulin actions; positron emission tomography (PET)
Publications
- Finnish-specific AKT2 gene variant leads to impaired insulin signalling in myotubes (2023)
- Journal of Molecular Endocrinology
(Refereed journal article or data article (A1)) - Finnish-specific AKT2 gene variant leads to impaired insulin signalling in human myotubes (2022)
- Diabetologia
(Other (O2)) - Obesity risk is associated with brain glucose uptake and insulin resistance (2022)
- European Journal of Endocrinology
(Refereed journal article or data article (A1)) - Effects of 6 weeks of treatment with dapagliflozin, a sodium- glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study (2021)
- Diabetes, Obesity and Metabolism
(Refereed journal article or data article (A1)) - Insulin-stimulated brain glucose uptake correlates negatively with peripheral insulin sensitivity already in the early phase of metabolic dysregulation (2021)
- Diabetologia
(Other (O2)) - Both sedentary time and physical activity are associated with cardiometabolic health in overweight adults in a 1 month accelerometer measurement (2020)
- Scientific Reports
(Refereed journal article or data article (A1)) - Brain insulin sensitivity is linked to body fat distribution-the positron emission tomography perspective (2020)
- European Journal of Nuclear Medicine and Molecular Imaging
(Article or data-article in scientific journal (B1)) - Predicting Skeletal Muscle and Whole-Body Insulin Sensitivity Using NMR-Metabolomic Profiling (2020)
- Journal of the Endocrine Society
(Refereed journal article or data article (A1)) - Regulators of central and peripheral insulin sensitivity in humans (2020) Latva-Rasku Aino
(Doctoral dissertation (article) (G5)) - Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study (2019)
- Upsala Journal of Medical Sciences
(Refereed journal article or data article (A1)) - The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients (2019)
- Diabetes Care
(Refereed journal article or data article (A1)) - A Partial Loss-of-Function Variant in AKT2 is Associated with Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin Sensitive Tissues: a Genotype-Based Callback Positron Emission Tomography Study (2018)
- Diabetes
(Refereed journal article or data article (A1)) - Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: A positron emission tomography study (2018)
- European Journal of Endocrinology
(Refereed journal article or data article (A1))